Animated videos aim to boost diabetes eye care follow-up
NCT ID NCT07519707
First seen Jun 24, 2026 · Last updated Jul 23, 2026 · Updated 3 times
Summary
This study tests whether showing patients with diabetes short animated videos (in English or Spanish) about diabetic eye disease can improve their understanding and increase how often they return for follow-up eye exams. About 150 patients at Zuckerberg San Francisco General Hospital will watch the videos during a clinic visit. Researchers will measure changes in knowledge and check electronic records to see if follow-up rates improve.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Animated videos (behavioral intervention)
- What this could lead to
- If successful, this could show that simple educational videos improve patient understanding and follow-up attendance for diabetic eye care.
- What could go wrong
- This is a small, early-stage study without a control group, so results may not be generalizable. The videos may not change behavior or outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 150 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of diabetes mellitus with or without diabetic retinopathy * Scheduled visit to ZSFG clinic is specifically for diabetes mellitus or diabetic retinopathy care * Able to speak and understand English or Spanish Exclusion Criteria: * Unable to view or understand the videos due to significant vision obstruction or impairment
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetic retinopathy (DR) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Zuckerberg San Francisco General Hospital and Trauma Center
San Francisco, California, 94110, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a One-Time gene therapy offer lasting protection for diabetic retinopathy?
- Can tight blood sugar control protect the eyes? a study uses advanced imaging to find out
- Could the speed of blood sugar drop harm the eyes? a study puts it to the test.
- AI eye doctor: could a computer spot Blindness-Causing diseases faster than humans?
- Could a common supplement protect eyes in diabetes?
- Eye scan showdown: faricimab vs ranibizumab in diabetic retinopathy